Filing Details
- Accession Number:
- 0001179110-12-013369
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-27 14:06:13
- Reporting Period:
- 2012-08-23
- Filing Date:
- 2012-08-27
- Accepted Time:
- 2012-08-27 14:06:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1554331 | H. James Quigley | C/O Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-24 | 300 | $7.50 | 300 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-08-24 | 12,200 | $7.55 | 12,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2012-08-23 | 21,300 | $0.00 | 21,300 | $7.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,300 | 2022-08-22 | No | 4 | A | Direct |
Footnotes
- This option vests as to 1/4th of the total number of shares on 11/23/12 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 8/23/13, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 8/23/13) or in the event of a change in control (as determined by the issuer's board of directors).